These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 6150689)

  • 21. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
    Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of stress on drug-induced yawning: constant vs. intermittent stress.
    Tufik S; de Luca Nathan C; Neumann B; Hipólide DC; Lobo LL; de Medeiros R; Troncone LR; Braz S; Suchecki D
    Physiol Behav; 1995 Jul; 58(1):181-4. PubMed ID: 7667418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atropine increases pilocarpine-induced yawning behavior in paradoxical sleep deprived rats.
    Lobo LL; de Medeiros R; Hipólide DC; Tufik S
    Pharmacol Biochem Behav; 1995 Nov; 52(3):485-8. PubMed ID: 8545463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Biol Psychiatry; 1982 Aug; 17(8):937-46. PubMed ID: 6288127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of RG-tannin on yawning behaviour induced by apomorphine or physostigmine in rats.
    Starec M; Waitzová D; Elis J
    Act Nerv Super (Praha); 1989 Apr; 31(1):71-2. PubMed ID: 2571230
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic and cholinergic influences on morphine self-administration in rats.
    Glick SD; Cox RD
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):17-24. PubMed ID: 1188183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does REM sleep deprivation induce subsensitivity of presynaptic dopamine or postsynaptic acetylcholine receptors in the rat brain?
    Tufik S; Troncone LR; Braz S; Silva-Filho AR; Neumann BG
    Eur J Pharmacol; 1987 Aug; 140(2):215-9. PubMed ID: 3666018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.